Rhys C Roberts
Overview
Explore the profile of Rhys C Roberts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
545
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan S, Gunawardana N, Roberts R
BMJ Neurol Open
. 2024 Mar;
6(1):e000608.
PMID: 38496231
Background: The COVID-19 pandemic prompted rapid changes in outpatient neurology services and there remain unanswered questions regarding its long-term impact. First, what are the lasting changes of the pandemic on...
2.
Al-Hakem H, Doets A, Stino A, Zivkovic S, Andersen H, Willison H, et al.
Neurology
. 2023 Apr;
100(23):e2386-e2397.
PMID: 37076309
Background And Objectives: To investigate CSF findings in relation to clinical and electrodiagnostic subtypes, severity, and outcome of Guillain-Barré syndrome (GBS) based on 1,500 patients in the International GBS Outcome...
3.
Leonhard S, van der Eijk A, Andersen H, Antonini G, Arends S, Attarian S, et al.
Neurology
. 2022 Aug;
99(12):e1299-e1313.
PMID: 35981895
Background And Objectives: Infections play a key role in the development of Guillain-Barré syndrome (GBS) and have been associated with specific clinical features and disease severity. The clinical variation of...
4.
Doets A, Lingsma H, Walgaard C, Islam B, Papri N, Davidson A, et al.
Neurology
. 2021 Dec;
98(5):e518-e532.
PMID: 34937789
Background And Objectives: The clinical course and outcome of the Guillain-Barré syndrome (GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score (mEGOS), developed with data from...
5.
6.
Edgar J, Ho A, Laura M, Horvath R, Reilly M, Luzio J, et al.
Acta Neuropathol Commun
. 2020 Oct;
8(1):165.
PMID: 33059769
Autosomal dominant mutations in LITAF are responsible for the rare demyelinating peripheral neuropathy, Charcot-Marie-Tooth disease type 1C (CMT1C). The LITAF protein is expressed in many human cell types and we...
7.
Tchasovnikarova I, Timms R, Douse C, Roberts R, Dougan G, Kingston R, et al.
Nat Genet
. 2017 Jun;
49(7):1035-1044.
PMID: 28581500
Dominant mutations in the MORC2 gene have recently been shown to cause axonal Charcot-Marie-Tooth (CMT) disease, but the cellular function of MORC2 is poorly understood. Here, through a genome-wide CRISPR-Cas9-mediated...
8.
Ho A, Wagstaff J, Manna P, Wartosch L, Qamar S, Garman E, et al.
BMC Biol
. 2016 Dec;
14(1):109.
PMID: 27927196
Background: Mutations in Lipopolysaccharide-induced tumour necrosis factor-α factor (LITAF) cause the autosomal dominant inherited peripheral neuropathy, Charcot-Marie-Tooth disease type 1C (CMT1C). LITAF encodes a 17 kDa protein containing an N-terminal...
9.
Vijay S, Chiu M, Dacks J, Roberts R
Biochim Biophys Acta
. 2016 Apr;
1862(7):1279-90.
PMID: 27068304
Charcot-Marie-Tooth disease type 4C (CMT4C) is one of the commonest autosomal recessive inherited peripheral neuropathies and is associated with mutations in the Rab11 effector, SH3TC2. Disruption of the SH3TC2-Rab11 interaction...
10.